LncRNA expression profiles and validation in keloid and normal skin tissue

Liang,Xuebing; Ma,Lin; Long,Xiao; Wang,Xiaojun

doi:10.3892/ijo.2015.3177

LncRNA expression profiles and validation in keloid and normal skin tissue

Authors:
- Xuebing Liang
- Lin Ma
- Xiao Long
- Xiaojun Wang
View Affiliations

Affiliations: Division of Plastic Surgery, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, P.R. China, Division of Surgery, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, P.R. China
Published online on: September 22, 2015 https://doi.org/10.3892/ijo.2015.3177
Pages: 1829-1838

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Keloid is a type of pathological skin scar. Pathogenesis of keloid is complex and is not fully understood. lncRNA can regulate gene expression on different levels. It also participates in cell cycle regulation and cell proliferation. The present study investigated the potential biological function of lncRNA in keloid. We identified differential expression of lncRNAs and mRNAs between 3 pairs of keloid and normal skin tissue by microarray. Differentially expressed lncRNAs were validated by quantitative reverse transcriptase-PCR (qRT-PCR). Gene ontology (GO) and pathway analysis presented the characteristics of associated protein-coding genes. Additionally, a co-expression network of lncRNA and mRNA was constructed to find potential underlying regulation targets. There were 1,731 lncRNAs constantly upregulated and 782 downregulated, 1,079 mRNAs upregulated and 3,282 downregulated in keloid respectively (fold change ≥2.0, p<0.05). We chose, respectively, 3 upregulated and 1 downregulated lncRNA for qRT-PCR and results were consistent with microarray. Moreover, 11 pathways were related with upregulated transcripts and 44 with downregulated in keloid. The co-expression network revealed that one lncRNA was connected with numerous mRNAs, and vice versa. Furthermore, bioinformation analysis suggested that lncRNA CACNA1G-AS1 may be crucial to keloid formation. In conclusion, groups of lncRNAs were aberrantly expressed in keloid compared with normal skin tissue, which indicated that differentially expressed lncRNAs may play a key role in keloid formation. The present study provides new insights into keloid pathology and potential targets for treatment of keloid.

View Figures

View References

1	Halim AS, Emami A, Salahshourifar I and Kannan TP: Keloid scarring: Understanding the genetic basis, advances, and prospects. Arch Plast Surg. 39:184–189. 2012. View Article : Google Scholar : PubMed/NCBI
2	van Leeuwen MC, van der Wal MB, Bulstra AE, Galindo-Garre F, Molier J, van Zuijlen PP, van Leeuwen PA and Niessen FB: Intralesional cryotherapy for treatment of keloid scars: A prospective study. Plast Reconstr Surg. 135:580–589. 2015. View Article : Google Scholar : PubMed/NCBI
3	Erol OO, Gurlek A, Agaoglu G, Topcuoglu E and Oz H: Treatment of hypertrophic scars and keloids using intense pulsed light (IPL). Aesthetic Plast Surg. 32:902–909. 2008. View Article : Google Scholar : PubMed/NCBI
4	Juckett G and Hartman-Adams H: Management of keloids and hypertrophic scars. Am Fam Physician. 80:253–260. 2009.PubMed/NCBI
5	Mseddi M, Mesrati H, Ktaari S, Amouri M, Chaaben H, Boudaya S and Turki H: Treatment of keloid with phenol: A new therapy. Ann Dermatol Venereol. 141:493–499. 2014.(In French). View Article : Google Scholar : PubMed/NCBI
6	van Leeuwen MC, Bulstra AE, van Leeuwen PA and Niessen FB: A new argon gas-based device for the treatment of keloid scars with the use of intralesional cryotherapy. J Plast Reconstr Aesthet Surg. 67:1703–1710. 2014. View Article : Google Scholar : PubMed/NCBI
7	Nakashima M, Chung S, Takahashi A, Kamatani N, Kawaguchi T, Tsunoda T, Hosono N, Kubo M, Nakamura Y and Zembutsu H: A genome-wide association study identifies four susceptibility loci for keloid in the Japanese population. Nat Genet. 42:768–771. 2010. View Article : Google Scholar : PubMed/NCBI
8	Chen W, Fu X, Sun X, Sun T, Zhao Z and Sheng Z: Analysis of differentially expressed genes in keloids and normal skin with cDNA microarray. J Surg Res. 113:208–216. 2003. View Article : Google Scholar : PubMed/NCBI
9	Unahabhokha T, Sucontphunt A, Nimmannit U, Chanvorachote P, Yongsanguanchai N and Pongrakhananon V: Molecular signalings in keloid disease and current therapeutic approaches from natural based compounds. Pharm Biol. 53:457–463. 2015. View Article : Google Scholar
10	Murao N, Seino K, Hayashi T, Ikeda M, Funayama E, Furukawa H, Yamamoto Y and Oyama A: Treg-enriched CD4⁺ T cells attenuate collagen synthesis in keloid fibroblasts. Exp Dermatol. 23:266–271. 2014. View Article : Google Scholar : PubMed/NCBI
11	Kung JT, Colognori D and Lee JT: Long noncoding RNAs: Past, present, and future. Genetics. 193:651–669. 2013. View Article : Google Scholar : PubMed/NCBI
12	Bonasio R and Shiekhattar R: Regulation of transcription by long noncoding RNAs. Annu Rev Genet. 48:433–455. 2014. View Article : Google Scholar : PubMed/NCBI
13	He Y, Meng XM, Huang C, Wu BM, Zhang L, Lv XW and Li J: Long noncoding RNAs: Novel insights into hepatocelluar carcinoma. Cancer Lett. 344:20–27. 2014. View Article : Google Scholar
14	Martens-Uzunova ES, Böttcher R, Croce CM, Jenster G, Visakorpi T and Calin GA: Long noncoding RNA in prostate, bladder, and kidney cancer. Eur Urol. 65:1140–1151. 2014. View Article : Google Scholar : PubMed/NCBI
15	Hombach S and Kretz M: The non-coding skin: Exploring the roles of long non-coding RNAs in epidermal homeostasis and disease. BioEssays. 35:1093–1100. 2013. View Article : Google Scholar : PubMed/NCBI
16	Kretz M, Webster DE, Flockhart RJ, Lee CS, Zehnder A, Lopez-Pajares V, Qu K, Zheng GX, Chow J, Kim GE, et al: Suppression of progenitor differentiation requires the long noncoding RNA ANCR. Genes Dev. 26:338–343. 2012. View Article : Google Scholar : PubMed/NCBI
17	Boggio RF, Freitas VM, Cassiola FM, Urabayashi M and Machado-Santelli GM: Effect of a calcium-channel blocker (verapamil) on the morphology, cytoskeleton and collagenase activity of human skin fibroblasts. Burns. 37:616–625. 2011. View Article : Google Scholar
18	Kashiyama K, Mitsutake N, Matsuse M, Ogi T, Saenko VA, Ujifuku K, Utani A, Hirano A and Yamashita S: miR-196a down-regulation increases the expression of type I and III collagens in keloid fibroblasts. J Invest Dermatol. 132:1597–1604. 2012. View Article : Google Scholar : PubMed/NCBI
19	Liu Y, Yang D, Xiao Z and Zhang M: miRNA expression profiles in keloid tissue and corresponding normal skin tissue. Aesthetic Plast Surg. 36:193–201. 2012. View Article : Google Scholar
20	Liu Y, Wang X, Yang D, Xiao Z and Chen X: MicroRNA-21 affects proliferation and apoptosis by regulating expression of PTEN in human keloid fibroblasts. Plast Reconstr Surg. 134:561e–573e. 2014. View Article : Google Scholar : PubMed/NCBI
21	Di Gesualdo F, Capaccioli S and Lulli M: A pathophysiological view of the long non-coding RNA world. Oncotarget. 5:10976–10996. 2014. View Article : Google Scholar : PubMed/NCBI
22	Kretz M: TINCR, staufen1, and cellular differentiation. RNA Biol. 10:1597–1601. 2013. View Article : Google Scholar : PubMed/NCBI
23	Bikle DD: The vitamin D receptor: A tumor suppressor in skin. Discov Med. 11:7–17. 2011.PubMed/NCBI
24	Jiang YJ and Bikle DD: LncRNA profiling reveals new mechanism for VDR protection against skin cancer formation. J Steroid Biochem Mol Biol. 144pa:87–90. 2014.
25	Wan DC and Wang KC: Long noncoding RNA: Significance and potential in skin biology. Cold Spring Harb Perspect Med. 4:1–10. 2014. View Article : Google Scholar
26	Mazar J, Zhao W, Khalil AM, Lee B, Shelley J, Govindarajan SS, Yamamoto F, Ratnam M, Aftab MN, Collins S, et al: The functional characterization of long noncoding RNA SPRY4-IT1 in human melanoma cells. Oncotarget. 5:8959–8969. 2014. View Article : Google Scholar : PubMed/NCBI
27	Wang KC and Chang HY: Molecular mechanisms of long noncoding RNAs. Mol Cell. 43:904–914. 2011. View Article : Google Scholar : PubMed/NCBI
28	Fukunaga K: Cognitive Function and Calcium. Cognitive improvement through T type calcium channel stimulation. Clin Calcium. 25:247–254. 2015.(In Japanese). PubMed/NCBI
29	Toyota M, Ho C, Ohe-Toyota M, Baylin SB and Issa JP: Inactivation of CACNA1G, a T-type calcium channel gene, by aberrant methylation of its 5′ CpG island in human tumors. Cancer Res. 59:4535–4541. 1999.PubMed/NCBI
30	Ohkubo T and Yamazaki J: T-type voltage-activated calcium channel Cav3.1, but not Cav3.2, is involved in the inhibition of proliferation and apoptosis in MCF-7 human breast cancer cells. Int J Oncol. 41:267–275. 2012.PubMed/NCBI
31	Villegas VE and Zaphiropoulos PG: Neighboring gene regulation by antisense long non-coding RNAs. Int J Mol Sci. 16:3251–3266. 2015. View Article : Google Scholar : PubMed/NCBI
32	Zhang ZZ, Shen ZY, Shen YY, Zhao EH, Wang M, Wang CJ, Cao H and Xu J: HOTAIR long noncoding RNA promotes gastric cancer metastasis through suppression of Poly r(C) Binding Protein (PCBP) 1. Mol Cancer Ther. 14:1162–1170. 2015. View Article : Google Scholar : PubMed/NCBI
33	Xue Y, Ma G, Zhang Z, Hua Q, Chu H, Tong N, Yuan L, Qin C, Yin C, Zhang Z, et al: A novel antisense long noncoding RNA regulates the expression of MDC1 in bladder cancer. Oncotarget. 6:484–493. 2015. View Article : Google Scholar :
34	Ledon JA, Savas J, Franca K, Chacon A and Nouri K: Intralesional treatment for keloids and hypertrophic scars: A review. Dermatol Surg. 39:1745–1757. 2013. View Article : Google Scholar : PubMed/NCBI
35	D'Andrea F, Brongo S, Ferraro G and Baroni A: Prevention and treatment of keloids with intralesional verapamil. Dermatology. 204:60–62. 2002. View Article : Google Scholar : PubMed/NCBI
36	Huang C and Ogawa R: Pharmacological treatment for keloids. Expert Opin Pharmacother. 14:2087–2100. 2013. View Article : Google Scholar : PubMed/NCBI
37	Giugliano G, Pasquali D, Notaro A, Brongo S, Nicoletti G, D'Andrea F, Bellastella A and Sinisi AA: Verapamil inhibits interleukin-6 and vascular endothelial growth factor production in primary cultures of keloid fibroblasts. Br J Plast Surg. 56:804–809. 2003. View Article : Google Scholar : PubMed/NCBI
38	Wu W, Okamoto O, Kato A, Matsuo N, Nomizu M, Yoshioka H and Fujiwara S: Dermatopontin regulates fibrin formation and its biological activity. J Invest Dermatol. 134:256–263. 2014. View Article : Google Scholar
39	Wang H, Liu J, Wang F, Chen M, Xiao Z, Ouyang R, Fei A, Shen Y and Pan S: The role of charged multivesicular body protein 5 in programmed cell death in leukemic cells. Acta Biochim Biophys Sin (Shanghai). 45:383–390. 2013. View Article : Google Scholar
40	Abuharbeid S, Czubayko F and Aigner A: The fibroblast growth factor-binding protein FGF-BP. Int J Biochem Cell Biol. 38:1463–1468. 2006. View Article : Google Scholar